NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

LeMaitre Vascular, Inc. (LMAT) Stock Analysis

LeMaitre Vascular, Inc. (LMAT) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

LMAT

$83.67

+$0.27 (+0.32%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare LMAT with… →

LMAT Key Statistics

As of Oct 21, 2026
Trading
Open
$82.71
Previous Close
$83.40
Day's Range
81.93–84.04
52-Week Range
78.22–118.01
Volume
216.66K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.47
Valuation
Market Cap
$1.91B
P/E Ratio
29.36
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
26.32
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
2.20
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
7.29
EPS (ttm)Profit attributable to each share over the last twelve months.
2.85
Financials (FY)
Revenue (FY)
$249.60M+13.53%
Net Income (FY)
$57.73M+31.10%
Profit marginThe share of revenue left as profit after all costs and taxes.
25.02%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
22.87M
1-Year Return
−6.11%
Dividend and dates
Dividend
$1.00+1.20%
Ex-Dividend Date
August 20, 2026
Earnings Date
November 4, 2026
Avg Volume
330.10K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, LMAT closed at $83.67, −6.11% over 1 year.

LeMaitre Vascular, Inc. (LMAT) has a market capitalization of $1.91B.

In fiscal 2025, LMAT reported revenue of $249.60M.

LMAT Stock Return by Calendar Year

LeMaitre Vascular, Inc. (LMAT) 10-year return: what $10,000 became

1 year
$10,000 $9,389
−6.11%
5 years
$10,000 $15,998
+59.98%
10 years
$10,000 $46,203
+362.03%

If you had invested $10,000 in LeMaitre Vascular, Inc. (LMAT) 10 years ago, at the close on October 21, 2016, it would have been worth $46,203 at the close on October 21, 2026: +362.03% in total, +16.54% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+3.66%
2025−11.16%
2024+63.63%
2023+24.60%
2022−7.40%
2021+25.10%
2020+14.09%
2019+53.77%
2018−25.13%
2017+26.58%
2016 (partial year)+47.82%

As of October 21, 2026.

LMAT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$249.60M$57.73M23.1%
2024$219.86M$44.04M20.0%
2023$193.48M$30.11M15.6%
2022$161.65M$20.64M12.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$249.60M$178.54M$67.91M$57.73M23.1%
2024$219.86M$150.90M$52.26M$44.04M20.0%
2023$193.48M$127.05M$37.20M$30.11M15.6%
2022$161.65M$104.90M$29.94M$20.64M12.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

LMAT Dividend History

$0.80+25.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.753—
2025$0.804+25.0%
2024$0.644+14.3%
2023$0.564+12.0%
YearDividends per sharePaymentsChange
2026 (partial year)$0.753—
2025$0.804+25.0%
2024$0.644+14.3%
2023$0.564+12.0%
2022$0.504+13.6%
2021$0.444+15.8%
2020$0.384+11.8%
2019$0.344+21.4%
2018$0.284+27.3%
2017$0.224+388.9%
2016$0.051—

Most recent payment: $0.25 per share, ex-dividend August 20, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

LMAT Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricLMATMedical Instruments & Supplies medianvs median
P/E29.3631.196% below
P/S ratio7.292.60181% above
Profit margin25.02%1.62%23.4 pts above

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 15 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

LeMaitre Vascular, Inc. (LMAT) is capitalised at $1.91B on the latest close. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 646 employees.

LMAT last closed at $83.67 on October 21, 2026. That is +$0.27 (+0.32%) against the previous close. The 52-week range on file runs from $78.22 to $118.01. The latest close sits 6.97% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $249.60M. That is +13.53% against the prior fiscal year, when revenue was $219.86M. Net income for the same year was $57.73M. That is +31.10% against the prior fiscal year. Profit margin runs at 25.02%. That is 23.4 percentage points above the Medical Instruments & Supplies median of 1.62%. Earnings per share on a trailing basis come to 2.85.

Across the 4 fiscal years on file, revenue moves from $161.65M in 2022 to $249.60M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

LMAT trades at a trailing price-to-earnings ratio of 29.36. That is 5.87% below the Medical Instruments & Supplies median of 31.19. On forward earnings the ratio is 26.32. The PEG ratio, which sets the P/E against expected earnings growth, reads 2.2. The price-to-sales ratio is 7.29. On price-to-sales that is 180.68% above the Medical Instruments & Supplies median of 2.6. 50 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is −6.11%. Measured over 10 years, that is +16.54% a year compounded. Beta against the wider market is reported at 0.47. Daily returns over the trailing 10 years annualize to a volatility of 41.76%.

Growth & Income

LMAT pays a dividend yielding 1.2%. That is 0.2 percentage points above the Medical Instruments & Supplies median yield of 1.04%. The indicated annual rate is $1.00 a share. The ex-dividend date on file is August 20, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $0.75 a share. The year before, 2025, totalled $0.80 a share.

So far in 2026 the total return is +3.66%. Across the complete calendar years on file, 2024 returned +63.63% and 2018 returned −25.13%. Of the 9 complete calendar years on file, 6 finished higher.

Peer Comparison

LeMaitre Vascular, Inc. (LMAT) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
LeMaitre Vascular, Inc. LMAT $1.91B 29.4
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. LeMaitre Vascular, Inc. trades at a P/E of 29.4.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Visit website →